Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Amit Gupta, CEO, sold 17,733 shares of Cardlytics, Inc. at $2.53 to $2.71 a share (average $2.64) in 2 transactions, worth $46.7K in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 138,906 (-5.0%).
Nurix Therapeutics CLO Christine Ring Sells $134K of Stock
Christine Ring, CLO, sold 5,786 shares of Nurix Therapeutics, Inc. at $23.19 a share, worth $134K in total on Oct 2, 2026. Shares held after the trade: 9,110 (-38.8%).
PTC Therapeutics Director Glenn Steele Jr. Md. Phd. Sells $782K of Stock
Glenn Steele Jr. Md. Phd., Director, sold 12,000 shares of PTC Therapeutics, Inc. at $65.16 a share, worth $782K in total on Sep 30, 2026. Shares held after the trade: 22,500 (-34.8%).
Rocket Lab CFO Adam C. Spice Sells $9.93M of Stock
Adam C. Spice, CFO, sold 140,157 shares of Rocket Lab Corp at $70.28 to $71.79 a share (average $70.82) in 3 transactions, worth $9.93M in total on Oct 1, 2026. Shares held after the trade: 1,155,967 (-1.3%).
Raymond Woo, CTO, sold 4,887 shares of Ceribell, Inc. at $24.38 a share, worth $119K in total on Oct 1, 2026. Shares held after the trade: 203,118 (-2.3%).
Oramed Pharmaceuticals CFO Avraham Gabay Sells $90.2K of Stock
Avraham Gabay, CFO, sold 20,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $90.2K in total on Oct 1, 2026. Shares held after the trade: 861,076 (-2.3%).
Joshua Hexter, COO & Cbo, sold 30,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $135K in total on Oct 1, 2026. Shares held after the trade: 1,328,130 (-2.2%).
Verastem President and CEO Dan Paterson Sells $353K of Stock
Dan Paterson, President and CEO, sold 44,121 shares of Verastem, Inc. at $8.00 a share, worth $353K in total on Oct 1, 2026. Shares held after the trade: 652,712 (-6.3%).
Daniel Calkins, CFO, sold 2,566 shares of Verastem, Inc. at $8.00 a share, worth $20.5K in total on Oct 1, 2026. Shares held after the trade: 123,781 (-2.0%).
Coursera President & CEO Gregory M. Hart Sells $52.6K of Stock
Gregory M. Hart, President & CEO, sold 10,308 shares of Coursera, Inc. at $5.11 a share, worth $52.6K in total on Oct 1, 2026. Shares held after the trade: 1,539,003 (-0.7%).
Generac Holdings CEO Aaron Jagdfeld Sells $1.03M of Stock
Aaron Jagdfeld, CEO, sold 5,000 shares of Generac Holdings Inc. at $206.00 a share, worth $1.03M in total on Oct 1, 2026. Shares held after the trade: 544,528 (-0.9%).
Warby Parker Insider Jeffrey Jacob Raider Sells $416K of Stock
Jeffrey Jacob Raider sold 15,000 shares of Warby Parker Inc. at $27.70 a share, worth $416K in total on Oct 1, 2026. Shares held after the trade: 420,201 (-3.4%).
Warby Parker Co-CEO Neil Harris Blumenthal Sells $2.77M of Stock
Neil Harris Blumenthal, Co-CEO, sold 100,000 shares of Warby Parker Inc. at $27.69 a share, worth $2.77M in total on Oct 1, 2026. Shares held after the trade: 36,020 (-73.5%).
Tectonic Therapeutic CSO Peter McNamara Sells $12.3K of Stock
Peter McNamara, CSO, sold 536 shares of Tectonic Therapeutic, Inc. at $23.04 a share, worth $12.3K in total on Sep 30, 2026. Shares held after the trade: 54,305 (-1.0%).
Bloom Energy Chief Commercial Officer Aman Joshi Sells $2.34M of Stock
Aman Joshi, Chief Commercial Officer, sold 8,437 shares of Bloom Energy Corp at $277.17 a share, worth $2.34M in total on Oct 1, 2026. Shares held after the trade: 147,092 (-5.4%).
Credo Technology Group Holding COO Yat Tung Lam Sells $10.3M of Stock
Yat Tung Lam, COO, sold 50,000 shares of Credo Technology Group Holding Ltd at $205.22 a share, worth $10.3M in total on Oct 1, 2026. Shares held after the trade: 2,254,169 (-2.2%).
Maximus Chief of Human Resources Michelle F. Link Sells $174K of Stock
Michelle F. Link, Chief of Human Resources, sold 3,208 shares of Maximus, Inc. at $54.23 a share, worth $174K in total on Oct 1, 2026. Shares held after the trade: 13,881 (-18.8%).
Verisign EVP, Gen Counsel & Secretary Thomas C. Indelicarto Sells $142K of Stock
Thomas C. Indelicarto, EVP, Gen Counsel & Secretary, sold 500 shares of Verisign Inc at $284.38 a share, worth $142K in total on Oct 1, 2026. Shares held after the trade: 32,395 (-1.5%).
Xeris Biopharma Holdings Insider Steven Pieper Sells $47K of Stock
Steven Pieper sold 5,000 shares of Xeris Biopharma Holdings, Inc. at $9.41 a share, worth $47K in total on Oct 1, 2026. Shares held after the trade: 1,351,053 (-0.4%).
Xeris Biopharma Holdings Insider Kevin McCulloch Sells $141K of Stock
Kevin McCulloch sold 15,000 shares of Xeris Biopharma Holdings, Inc. at $9.41 a share, worth $141K in total on Oct 1, 2026. Shares held after the trade: 1,599,208 (-0.9%).
Xeris Biopharma Holdings Insider Beth Hecht Sells $157K of Stock
Beth Hecht sold 16,666 shares of Xeris Biopharma Holdings, Inc. at $9.41 a share, worth $157K in total on Oct 1, 2026. Shares held after the trade: 1,111,130 (-1.5%).
BeOne Medicines SVP, General Counsel Chan Henry Lee Sells $418K of Stock
Chan Henry Lee, SVP, General Counsel, sold 1,115 shares of BeOne Medicines Ltd. at $375.00 a share, worth $418K in total on Sep 30, 2026. Shares held after the trade: 0 (-100.0%).
BJ's Wholesale Club Holdings EVP, Chief Growth Officer Timothy Pierce Morningstar Sells $457K of Stock
Timothy Pierce Morningstar, EVP, Chief Growth Officer, sold 4,856 shares of BJ's Wholesale Club Holdings, Inc. at $94.09 a share, worth $457K in total on Oct 1, 2026. Shares held after the trade: 33,924 (-12.5%).
H&R Block Chief Retail Officer Mark J. Darling Sells $110K of Stock
Mark J. Darling, Chief Retail Officer, sold 2,700 shares of H&R Block Inc at $40.69 a share, worth $110K in total on Sep 30, 2026. Shares held after the trade: 21,588 (-11.1%).
BJ's Wholesale Club Holdings EVP, Strategy & Development William C. Werner Sells $285K of Stock
William C. Werner, EVP, Strategy & Development, sold 3,000 shares of BJ's Wholesale Club Holdings, Inc. at $95.00 a share, worth $285K in total on Oct 1, 2026. Shares held after the trade: 50,160 (-5.6%).
Nwpx Infrastructure SVP and Group President of WTS Eric Stokes Sells $1.28M of Stock
Eric Stokes, SVP and Group President of WTS, sold 12,353 shares of Nwpx Infrastructure, Inc. at $103.38 a share, worth $1.28M in total on Oct 1, 2026. Shares held after the trade: 25,274 (-32.8%).
On Semiconductor Group President, AMG & ISG Sudhir Gopalswamy Sells $1.25M of Stock
Sudhir Gopalswamy, Group President, AMG & ISG, sold 15,578 shares of On Semiconductor Corp at $80.00 a share, worth $1.25M in total on Oct 1, 2026. Shares held after the trade: 158,177 (-9.0%).
Powell Industries VP, R&D William Marshall Mauney Jr. Sells $56.5K of Stock
William Marshall Mauney Jr., VP, R&D, sold 301 shares of Powell Industries Inc at $187.67 a share, worth $56.5K in total on Sep 30, 2026. Shares held after the trade: 10,552 (-2.8%).
Gilead Sciences Chairman & CEO Daniel Patrick O'Day Sells $2.22M of Stock
Daniel Patrick O'Day, Chairman & CEO, sold 15,000 shares of Gilead Sciences, Inc. at $147.72 to $148.63 a share (average $147.90) in 2 transactions, worth $2.22M in total on Oct 1, 2026. Shares held after the trade: 566,683 (-0.5%).
Halozyme Therapeutics Insider Matthew L. Posard Sells $568K of Stock
Matthew L. Posard sold 5,230 shares of Halozyme Therapeutics, Inc. at $107.17 to $110.04 a share (average $108.54) in 4 transactions, worth $568K in total on Oct 1, 2026. Shares held after the trade: 53,609 (-0.2%).